BioHarvest Sciences Q1 2025 Earnings EPS Misses Estimates Stock Gains Amid Operational Progress Nabors Industries Q1 2026 Earnings Earnings Beat Estimates but Stock Slips CLRB Q1 2026 Earnings EPS Surprise Signals Progress Despite PreRevenue Status ProQR Therapeutics Q1 2026 Earnings Narrower Net Loss No Revenue as Pipeline Progress Drives Stock Gains Enterprise Financial Services Corporation EFSCP Q1 2026 Earnings Slight EPS Miss Amid Solid Capital Performance Legend Biotech LEGN Q1 2026 Earnings Significant EPS Miss Against Estimates as Stock Rises